Table 2.
LGCPs | ||||
---|---|---|---|---|
All cancers | Leukaemia | Lymphoma | CNS tumours | |
unadjusteda (median, 95% CI) | 0.01 (0, 0.02) | 0.00 (0, 0.03) | 0.01 (0, 0.04) | 0.02 (0.01, 0.06) |
adjustedb (median, 95% CI) | 0.01 (0, 0.03) | 0.00 (0, 0.01) | 0.00 (0, 0.03) | 0.02 (0, 0.06) |
Variation explainedc (median; 95% CI) | 0.72 (0.43, 0.89) | 0.81 (0.58, 0.94) | 0.82 (0.60, 0.94) | 0.64 (0.31, 0.84) |
RR unadjusteda (median; ranged) | 0.99 (0.83, 1.13) | 1.00 (0.96, 1.09) | 0.99 (0.9, 1.13) | 1.01 (0.82, 1.23) |
RR adjustedb (median; ranged) | 1.02 (0.86, 1.08) | 1.00 (0.97, 1.04) | 1.00 (0.96, 1.07) | 1.00 (0.87, 1.25) |
CI credibility intervals, RR grid specific relative risk compared to Switzerland as a whole, LGCP log-Gaussian Cox process, CNS Central and Nervous System
aThe unadjusted model refers to the models without any covariates
bAdjusted for NO2, background radiation, years of general cancer registration, linguistic region and degree of urbanicity
cVariation explained by the covariates from the fully adjusted model, defined as where denotes the variance over the spatial units, is the vector of intercept and covariates, the design matrix and the Gaussian field. The variation here refers to the fully adjusted model
dRange is defined as [min, max]